Pfizer's payout ratio is around 90% of earnings, which is high for a dividend stock. It reported strong operational growth of ...

Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

Pfizer's diversified pipeline and new product launches are driving operational growth. Click here to read more about PFE ...

Pfizer's forward dividend yield currently stands at 6.86%. This yield is so attractive that I wondered if it's the highest of ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

All of us could use a little more monthly income; it’s not just for retired folks anymore. Considering the state of the economy and the rising household expenses, the idea of receiving a monthly ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate PFE stock a Sell.

Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

Realty Income is a real estate investment trust that has raised its dividend payout 131 times since 1994. Verizon's a ...

These three dividend stocks are trading on the cheap given their true valuations. They should be on income investors' radars.

Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...

One of the most appealing features of Pfizer's stock is its dividend. The payout recently yielded a hefty 7.4% -- and it's been growing over time. There's reason to be bullish over Pfizer's long-term ...